Skip to main content
. 2018 Oct 26;19(11):3352. doi: 10.3390/ijms19113352

Figure 12.

Figure 12

Cell representation (%) within the four quadrants for MDA-MB-468 cell treatments. Percent distribution of MDA-MB-468 apoptotic cells after treatment with H2O2, Sutent, Selenite as Se, Bevacizumab (BV), Selenobevacizumab (Se-BV), Trastuzumab (TZ), or Selenotrastuzumab (Se-TZ). Data is expressed as the Mean (n = 3).